|
Environmental Catalysts and
Technologies (ECT)
ECT comprises Johnson Matthey’s global autocatalyst,
heavy duty diesel and stationary source emission control businesses.
We are the world’s leading manufacturer of catalysts for vehicle
exhaust emission control and a leader in catalyst systems for the
reduction of volatile organic compound emissions from industrial
processes. Manufacturing takes place in the USA, UK, Belgium, Mexico,
Argentina, South Africa, Malaysia, India and China. R&D facilities
are in the USA, UK, Sweden, Japan and Brazil.
Process Catalysts and Technologies
(PCT)
PCT manufactures base and precious metal process
catalysts, fine chemicals and electrochemical products. Our platinum
group metal (pgm) refining business recovers spent catalysts and
other secondary material and also refines primary pgms from global
mining operations. Manufacturing facilities are in the UK, USA,
Germany, India and China. Our Research Chemicals business is based
in the USA and UK.
Fuel Cells
Johnson Matthey is the world leader in catalysts
and catalysed components for fuel cells.
|
|
Our Precious Metals Division is organised into
two groups; Platinum and Gold and Silver, and incorporates Johnson
Matthey’s precious metals marketing, fabrication and refining
activities.
Platinum
Consists of our worldwide platinum marketing and
fabrication activities. Marketing is headquartered in London with
support facilities in Philadelphia and Hong Kong. We are the world’s
leading distributor of platinum group metals and the sole marketing
agent for Anglo Platinum, the world’s largest producer of platinum.
Our platinum fabrication business makes a wide range of platinum
group metal products primarily in the UK and USA.
Gold and Silver
Comprises our worldwide gold and silver refining
and bullion manufacturing operations. Johnson Matthey is the market
leader in the refining of gold and silver. The business serves the
world’s mining industries and recycles secondary scrap material.
We are also a leading manufacturer of high purity small gold bars
for investment and jewellery manufacture. Gold and silver refining
operations are located in the UK, USA, Canada and Hong Kong.
|
|
Colours & Coatings Division is ranked among
the world’s top integrated suppliers of decorative products
and associated raw materials for ceramics and glass. The division
is structured into three businesses; Glass, Structural Ceramics
and Speciality Coatings, which are organised around the key markets
that we serve.
Glass
Based in the Netherlands, our Glass business manufactures
black obscuration and silver conductive enamels for automotive glass.
It also makes enamels and decorative precious metal products for
other glass applications such as bottles and architectural glass.
Structural Ceramics
Our Structural Ceramics business manufactures
colours, glazes and frits for the tile and sanitaryware industries,
and includes our zircon business.
Speciality Coatings
Speciality Coatings supplies colours, glazes,
decals and decorative precious metal products to manufacturers of
fine china in the UK and around the world. It also produces a wide
range of inorganic pigments and pigment dispersions for use in printing
inks, paints, automotive finishes, woodstains and plastics.
|
|
Pharmaceutical Materials Division is a global, integrated supplier
of active pharmaceutical ingredients, which provides services to
pharmaceutical companies through every phase of the development
of a new product.
Serving their respective markets in the US and Europe, the division’s
West Deptford and Macfarlan Smith operations provide customers with
bulk manufacturing services from Phase Three clinical trials through
commercialisation of a patented or generic drug. The division has
leading positions in the manufacture of controlled substances and
platinum based anticancer drugs.
The division’s Pharm-Eco Laboratories business provides contract
research and development and small scale manufacturing services
from pre-clinical through to Phase Three clinical trials.
Its Cascade Biochem business is focused on the manufacture of prostaglandins
and other complex molecules as active pharmaceutical ingredients
for the pharmaceutical industry.
|
